Join over 250 leaders, experts and scientists to discuss key opportunities and challenges in two distinct programmes covering Biomarker-based research and Immuno-Oncology based therapies
Featuring over 80 presentations, the series brings together leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective biomarker discovery and cancer immunotherapy development.
The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
The following are confirmed speakers for the 2019 series.
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of on-site experiences.